v3.26.1
SHARE-BASED COMPENSATION
6 Months Ended
Jun. 30, 2026
Share-Based Payment Arrangement [Abstract]  
SHARE-BASED COMPENSATION SHARE-BASED COMPENSATION
 
Certain key employees and non-employee directors participate in the Amended and Restated 2014 Equity Participation Plan of Civeo Corporation (the Civeo Plan). The Civeo Plan authorizes our Board and the Compensation Committee of our Board to approve and grant awards of options, awards of share appreciation rights, awards of restricted shares, performance share awards, phantom share units and dividend equivalents, awards of deferred shares, and share payments to our employees and non-employee directors. Approximately 3.5 million Civeo common shares are authorized to be issued under the Civeo Plan.
 
Outstanding Awards 
 
Phantom Share Units. On March 5, 2026, we granted 132,804 phantom share units under the Civeo Plan, which vest in three equal annual installments beginning on March 5, 2027. We also granted 44,187 phantom share units under the Canadian Long-Term Incentive Plan, which vest in three equal annual installments beginning on March 5, 2027. Phantom share units are settled in cash upon vesting.

During the three months ended June 30, 2026 and 2025, we recognized compensation expense associated with phantom share units totaling $2.2 million and $1.5 million, respectively. During the six months ended June 30, 2026 and 2025, we recognized compensation expense associated with phantom share units totaling $4.6 million and $3.3 million, respectively. At June 30, 2026, unrecognized compensation cost related to phantom share units was $11.9 million, as remeasured at June 30, 2026, which is expected to be recognized over a weighted average period of 2.0 years.
 
Performance Share Awards. On March 5, 2026, we granted 144,433 performance share awards under the Civeo Plan, which cliff vest after three years subject to attainment of applicable performance goals. These awards will be earned in amounts between 0% and 200% of the participant’s target performance share award, based on the payout percentage associated with Civeo’s relative total shareholder return rank among a peer group of other companies and the payout percentage associated with Civeo's three-year growth in EBITDA over the performance period relative to a preset 2028 EBITDA target. The portion of the performance share awards tied to the 2028 EBITDA target includes a performance-based vesting requirement. We evaluate the probability of achieving the performance goals throughout the performance period and will adjust share-based compensation expense based on the number of shares expected to vest based on our estimate of the most probable performance outcome. No share-based compensation expense is recognized if the performance criteria are not probable of being achieved.

During the three months ended June 30, 2026 and 2025, we recognized compensation expense associated with performance share awards totaling $0.3 million and $0.3 million, respectively. During the six months ended June 30, 2026 and 2025, we recognized compensation expense associated with performance share awards totaling $0.2 million and $0.7 million, respectively. No performance share awards vested during the three months ended June 30, 2026 and 2025. The total fair value of performance share awards that vested during the six months ended June 30, 2026 and 2025 was $0.9 million and $1.7 million, respectively. At June 30, 2026, unrecognized compensation cost related to performance share awards was $2.3 million, which is expected to be recognized over a weighted average period of 2.2 years. 

Restricted Share Awards / Deferred Share Awards. On May 27, 2026, we granted 30,224 restricted share and deferred share awards to our non-employee directors, which vest in their entirety in May 2027.

Compensation expense associated with restricted share awards and deferred share awards recognized in the three months ended June 30, 2026 and 2025 totaled $0.3 million and $0.3 million, respectively. Compensation expense associated with restricted share awards and deferred share awards recognized in the six months ended June 30, 2026 and 2025 totaled $0.7 million and $0.5 million, respectively. The total fair value of restricted share awards and deferred share awards that vested during the three months ended June 30, 2026 and 2025 was $2.2 million and $0.9 million, respectively. The total fair value of restricted share awards and deferred share awards that vested during the six months ended June 30, 2026 and 2025 was $2.2 million and $0.9 million, respectively.
 
At June 30, 2026, unrecognized compensation cost related to restricted share awards and deferred share awards was $0.9 million, which is expected to be recognized over a weighted average period of 0.9 years.